Back to results
US 2023/0144292 A1Published application
Irak degraders and uses thereof
AssigneeKymera Therapeutics, Inc.
InventorMatthew M. WEISS
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds, compositions thereof, and methods of using the same.
Claims31
1-13. (canceled)
A compound selected from the group consisting of:
- or a pharmaceutically acceptable salt thereof.
A pharmaceutical composition comprising a compound selected from the group consisting of
- or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant, or vehicle.
Dependencies are inferred from the claim text.